Veru

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Veru and other ETFs, options, and stocks.

About VERU

Veru, Inc. is a late clinical stage biopharmaceutical company focused on developing novel medicines for the treatment of metabolic diseases, oncology, and ARDS. The company’s drug development program includes two late-stage novel small molecules, enobosarm and sabizabulin. 

CEO
Mitchell Shuster Steiner
CEOMitchell Shuster Steiner
Employees
210
Employees210
Headquarters
Miami, Florida
HeadquartersMiami, Florida
Founded
1971
Founded1971
Employees
210
Employees210

VERU Key Statistics

Market cap
89.17M
Market cap89.17M
Price-Earnings ratio
-2.84
Price-Earnings ratio-2.84
Dividend yield
Dividend yield
Average volume
2.16M
Average volume2.16M
High today
$0.65
High today$0.65
Low today
$0.5752
Low today$0.5752
Open price
$0.6158
Open price$0.6158
Volume
2.35M
Volume2.35M
52 Week high
$1.42
52 Week high$1.42
52 Week low
$0.45
52 Week low$0.45

People also own

Based on the portfolios of people who own VERU. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.